Yuyu Pharma Inc
Yuyu Pharma, Inc. develops and markets pharmaceutical products in Korea and United States. The company offers various prescription drugs, non-prescription drugs, quasi-drugs, health functional foods, and other products in the fields of neurology, endocrinology, otolaryngology, etc. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc.… Read more
Yuyu Pharma Inc - Asset Resilience Ratio
Yuyu Pharma Inc (000227) has an Asset Resilience Ratio of 1.74% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Yuyu Pharma Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Yuyu Pharma Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩3.65 Billion | 1.74% |
| Total Liquid Assets | ₩3.65 Billion | 1.74% |
Asset Resilience Insights
- Limited Liquidity: Yuyu Pharma Inc maintains only 1.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Yuyu Pharma Inc Industry Peers by Asset Resilience Ratio
Compare Yuyu Pharma Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Ildong Holdings Co Ltd
KO:000230 |
Drug Manufacturers - Specialty & Generic | 1.57% |
Annual Asset Resilience Ratio for Yuyu Pharma Inc (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Yuyu Pharma Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.39% | ₩817.27 Million | ₩207.69 Billion | -0.49pp |
| 2023-12-31 | 0.88% | ₩1.75 Billion | ₩198.21 Billion | -1.65pp |
| 2022-12-31 | 2.53% | ₩4.94 Billion | ₩195.21 Billion | +2.41pp |
| 2020-12-31 | 0.12% | ₩180.00 Million | ₩154.90 Billion | -0.29pp |
| 2018-12-31 | 0.40% | ₩545.95 Million | ₩135.23 Billion | -0.01pp |
| 2017-12-31 | 0.41% | ₩500.00 Million | ₩121.49 Billion | -0.05pp |
| 2016-12-31 | 0.46% | ₩509.59 Million | ₩111.30 Billion | -0.02pp |
| 2015-12-31 | 0.48% | ₩500.00 Million | ₩104.33 Billion | -0.06pp |
| 2014-12-31 | 0.54% | ₩550.00 Million | ₩101.40 Billion | -- |